Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Lansoprazole

Lansoprazole

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Lansoprazole

35 trials tracked of Lansoprazole: 17 in phase 3 or 4 and 3 with published results. The most-cited published study has 284 citations.

35Trials tracked
17Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 6 Phase 3 11 Phase 2 4 Phase 1 7 Other / NA 7
  1. Phase 3 Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection Completed · 284 cited
  2. Phase 3 Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis Completed · 141 cited
  3. Phase 4 Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety Completed · 40 cited
  4. Phase 4 Safety and Efficacy of Lansoprazole in Patients With Reflux Disease Completed
  5. Phase 4 Lansoprazole to Treat Children With Asthma Completed
  6. Phase 4 An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis Completed
Show 29 more trials
  1. Phase 4 Treatment of Zollinger-Ellison Syndrome With Prevacid Completed
  2. Phase 4 13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors) Completed
  3. Phase 3 Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis Completed
  4. Phase 3 Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive Esophagitis Completed
  5. Phase 3 Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection Completed
  6. Phase 3 Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis Completed
  7. Phase 3 Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis Completed
  8. Phase 3 Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs Completed
  9. Phase 3 Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout Completed
  10. Phase 3 Efficacy of Lansoprazole in Chronic Post Nasal Drip Completed
  11. Phase 3 Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection Completed
  12. Phase 2 Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain Completed
  13. Phase 2 Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment Completed
  14. Phase 2 Proof of Concept Study Efficacy of an Antacid/Lansoprazole Combination for Relief of Heartburn Completed
  15. Phase 2 A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole Completed
  16. Phase 1 A Study of LY2940680 in Healthy Participants Completed
  17. Phase 1 Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study Completed
  18. Phase 1 TAK-438 Bismuth Drug Interaction Study Completed
  19. Phase 1 Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan and Lansoprazole in Healthy Participants Completed
  20. Phase 1 A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants Completed
  21. Phase 1 Lansoprazole 30 mg DR Capsule Replicate Food Study Completed
  22. Phase 1 Lansoprazole 30 mg DR Capsule Fasting Study Completed
  23. N/A Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease Completed
  24. N/A Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs Completed
  25. N/A A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion Completed
  26. N/A Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions] Completed
  27. N/A Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate] Completed
  28. N/A Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia Symptoms Completed
  29. N/A Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin Completed

Showing the 35 most-cited and recently-updated of 35 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.